Some of current medications for type 2 diabetes mellitus, such as metformin, glimepiride, glucagon-like peptide-1 (GLP-1), and insulin, possibly played beneficial roles in bone metabolism (5–8). The gene discussed is GCG; the disease is diabetes mellitus.